about
Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophyEtiology matters - Genomic DNA Methylation Patterns in Three Rat Models of Acquired Epilepsy.Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expressionThe primary microRNA-208b interacts with Polycomb-group protein, Ezh2, to regulate gene expression in the heartNon-referenced genome assembly from epigenomic short-read dataNET silencing by let-7i in postural tachycardia syndrome.Quantification of gammaH2AX foci in response to ionising radiation.MDR1, chemotherapy and chromatin remodeling.HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.Set7 mediated interactions regulate transcriptional networks in embryonic stem cells.Interplay of chromatin modifications and non-coding RNAs in the heartEpigenetic changes in diabetes.Epigenetic-mediated reprogramming of pancreatic endocrine cells.Epigenetics and metabolism.Deep sequencing reveals novel Set7 networks.Multi-Cellular Transcriptional Analysis of Mammalian Heart Regeneration.Improving understanding of chromatin regulatory proteins and potential implications for drug discovery.Epigenetic Changes in Diabetes and Cardiovascular Risk.Epigenomic changes associated with impaired norepinephrine transporter function in postural tachycardia syndrome.Metabolism and chromatin dynamics in health and disease.Evaluation of microRNA alignment techniques.RNA sequencing supports distinct reactive oxygen species-mediated pathways of apoptosis by high and low size mass fractions of Bay leaf (Lauris nobilis) in HT-29 cells.Epigenetics in diabetic nephropathy, immunity and metabolism.Epigenetic programming, early life nutrition and the risk of metabolic disease.The epigenetic contribution to the development and progression of vascular diabetic complications.Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes.DNA methylation regulates hypothalamic gene expression linking parental diet during pregnancy to the offspring's risk of obesity in Psammomys obesus.RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis.Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena.MeCP2 interacts with chromosomal microRNAs in brain.Pharmacological Histone Deacetylation Distinguishes Transcriptional Regulators.Pharmacological inhibition of arginine and lysine methyltransferases induces nuclear abnormalities and suppresses angiogenesis in human endothelial cells.Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.Transcription factors Tp73, Cebpd, Pax6, and Spi1 rather than DNA methylation regulate chronic transcriptomics changes after experimental traumatic brain injury.HDAC Inhibition in Vascular Endothelial Cells Regulates the Expression of ncRNAs.Current perspectives in Set7 mediated stem cell differentiation.Contemporary Trends Emerging in Epigenomics and MetabolismEndothelial Transcriptome in Response to Pharmacological Methyltransferase InhibitionGalectin-3 deficiency ameliorates fibrosis and remodelling in dilated cardiomyopathy mice with enhanced Mst1 signaling
P50
Q26864605-A3691D9A-ACFB-4C52-8D78-6206364A61C8Q27316575-4681CAD5-CB05-448C-9DF0-FE92175293BBQ28480965-D104F9B8-31B4-4BE5-B6BF-ED699265E279Q28586308-0263A329-CF95-4DB8-82A8-12559A80CECAQ30872605-80AEF927-535E-4403-898D-281520402C43Q33168474-EB678A34-4A5D-48CB-BE4A-1082059C2A0DQ35187338-057B6249-8FFB-46B4-95C9-0116CB824D06Q35869829-BB2F1FF2-A93D-4DF9-B3DE-17D2C93F7FBFQ36212830-562356D8-576C-4503-BE7A-20CF2585F99FQ36215430-99BC61DB-FB02-4D1C-985A-5B98E2C0F90DQ37401060-B50191E0-859F-4708-A144-15B076636A74Q37591520-5E1B2E58-1ABB-49D2-8728-91F20AC61893Q38080554-F4D5B907-7398-43D8-8427-835CD8825BCFQ38332689-C96DADD9-CCA4-45ED-8766-C967904EC8ACQ38353919-2DE9FF6E-3C97-4D75-9065-3823149CAAA8Q38476540-D59B1EC8-26B4-42FA-9A57-608C605C30F7Q38667300-F0B2E3E0-8258-444F-A8CE-1FD58CE90D8DQ38753861-0C8A8174-A589-497E-8A6C-D1338BE99FC8Q38845518-F2333DD3-044A-4EF6-BF48-5ACA3F480043Q38877328-0EB5C67C-C571-451B-BE3F-3BCEE558A14EQ38971129-67BBC07A-4528-4ABE-A0B4-B4AD7FD91EB1Q39694391-4470A83A-A259-42CD-9724-722374D5621BQ46709248-A5B026FB-8FCB-4101-B620-4121FAC43D2CQ47412518-3B20F9FF-C5EF-4D5B-8F0E-FE94C23FE488Q47741225-1046ED61-B5C1-4A94-BA95-2E14A3053549Q47749605-502DCE3E-B623-4B5D-9060-BB2AF9318219Q48666421-1AF36EB9-E206-4379-BC3C-5E2B7A814A8FQ48797543-9ED90D85-89ED-40B8-8AEE-9DE86B432B7CQ49960859-06E53DBC-4A59-44C2-8323-F382E0121055Q50082577-67076466-D85D-4AAB-A60E-802E9408EE6DQ50140785-1C71A503-BADA-4997-A9A5-D35315F5684FQ51339291-C636F5F7-DEA4-4400-A9BB-CD86B731658FQ51472268-C36FC791-94E3-4D5D-9EDE-618BCA5C7089Q52680904-82DA63C2-400B-4D3F-AD59-061C40FC3213Q55247467-7BD578E7-5B02-46AE-94CF-53F330DFCB83Q55323751-EE77E4C3-484B-4813-A7B3-E78DECEEB79BQ55456138-08F7FD09-EDFC-40A4-BAC2-FFE95805AEC7Q57282608-E6D9F8C9-1A8F-4DFA-BDA1-689DF0EC7540Q58049788-91D1AA2B-8891-4560-A4C5-50B55B87569EQ58615231-E3119BA6-11EC-40F7-A8C4-A7313D39F44D
P50
description
researcher, ORCID id # 0000-0003-2969-9137
@en
wetenschapper
@nl
name
Assam El-Osta
@ast
Assam El-Osta
@en
Assam El-Osta
@es
Assam El-Osta
@nl
type
label
Assam El-Osta
@ast
Assam El-Osta
@en
Assam El-Osta
@es
Assam El-Osta
@nl
prefLabel
Assam El-Osta
@ast
Assam El-Osta
@en
Assam El-Osta
@es
Assam El-Osta
@nl
P106
P31
P496
0000-0003-2969-9137